Finance Associated Press

Cambrian: Net loss of 443 million yuan in 2024

Today's Spotlight

[2 Lianban Wanma shares: the company's robot cable products are gradually applied to humanoid robots and robot dog products].

Wanma shares (002276.SZ) announced that the company has paid attention to the recent market attention to robot-related concepts, and the company's robot cable products in the cable sector and Wanma robot Zhilian CCa system can be applied to robot-related products. Such products are now mainly used in the field of industrial robots, and are also gradually applied to humanoid robots and robot dog products. Combined with the company's recent operating conditions, internal and external business environment analysis, the company's fundamentals have not undergone major changes recently. Investors are advised to invest rationally and pay attention to investment risks.

[Cambrian: net loss of 443 million yuan in 2024].

Cambrian (688256.SH) released a performance report, achieving operating income of 1.174 billion yuan in 2024, a year-on-year increase of 65.56%, and the net profit attributable to the owners of the parent company will be -443 million yuan. This was mainly due to the significant increase in operating income over the same period last year and the reversal of credit impairment losses during the reporting period.

[Baotong Technology: Recent exchanges and technical discussions with Unitree Technology related work is still advancing].

300031.SZ As a leading provider of industrial material transportation solutions in China, the company has recently conducted exchanges and technical discussions with Hangzhou Yushu Technology Co., Ltd. to explore the innovative application and implementation of industrial robot technology in mining, metal smelting, cement building materials, dock transfer and other scenarios, and related work is still advancing. At the same time, the company has also paid attention to the relevant matters reported by some media platforms, so please pay attention to the investment risks.

[Unisplendour: The company is conducting research and demonstration on equity financing in the Hong Kong capital market].

Tsinghua Unigroup (000938.SZ) announced that in order to deepen the company's global strategic layout, accelerate overseas business development, enhance the company's overseas financing ability, and further enhance the company's international brand image, the company is conducting research and demonstration on equity financing in the Hong Kong capital market. As of now, the company has not determined a specific timeline or specific plan. There are still significant uncertainties as to whether the Company will implement the above-mentioned matters, as well as the specific implementation plan and implementation time.

[Zhichun Technology: Plans to purchase 83.78% of the shares of Witton Crystal Phosphorus, and the shares will resume trading tomorrow].

Zhichun Technology (603690.SH) announced that the company intends to purchase 83.78% of the shares of Wittun Crystal Phosphorus held by 24 counterparties including Beijing Wittun International Trade Co., Ltd. through the issuance of shares and cash payment and raise matching funds. Upon completion of the transaction, Witton Crystal Phosphorus will become a holding subsidiary of the Company. The company's shares will resume trading from the market open on February 28, 2025. Witton Crystal Phosphorus is a state-level specialized and new "little giant" enterprise mainly engaged in the R&D, production and sales of high-purity electronic materials in the field of integrated circuits and photovoltaics.

[Allwinner Technology: net profit in 2024 will increase by 626% year-on-year].

Allwinner Technology (300458.SZ) released a performance report, with a total operating income of 2.288 billion yuan in 2024, a year-on-year increase of 36.76%, and a net profit attributable to shareholders of listed companies of 167 million yuan, a year-on-year increase of 625.82%. During the reporting period, the company actively grasped the opportunity of the recovery of downstream market demand, improved the product matrix, and vigorously expanded the business of automotive, industrial, consumer and other product lines, represented by sweeping robots, intelligent projection, pan-security and other business lines, and the shipment volume increased significantly, resulting in a year-on-year increase of 36.76% in operating income, a record high.

[Wall Nuclear Materials: Net profit in 2024 increased by 22.7% year-on-year].

Wall Nuclear Materials (002130.SZ) released a performance report, achieving a total operating income of 6.931 billion yuan in 2024, a year-on-year increase of 21.11%; The net profit attributable to shareholders of the listed company was 860 million yuan, a year-on-year increase of 22.70%. By increasing R&D and market development efforts, as well as improving automation level and production efficiency, the company has achieved an increase in operating income of electronic products, power products, wire products and new energy vehicle business-related products.

[SIE Information: Signed the sales contract for the product project of the AI middle platform and application pilot project].

SIE Information (300687.SZ) announced that the company recently signed a product project sales contract with customers on the AI middle platform and application pilot project, with a total amount of 48.4692 million yuan including tax. The contract is a daily operating contract of the company, which does not meet the disclosure standards and is a voluntary external disclosure. The services and products provided by the company focus on AI application scenarios such as intelligent network development and product design, including end-to-end capabilities such as data processing, large model training and fine-tuning, and AI application development based on the AI tool chain, and the ability to access DeepSeek large models.

BeiGene: 2025 revenue is expected to be between RMB35.2 billion and RMB38.1 billion

BeiGene (688235.SH) announced that its operating income in 2025 is expected to be between RMB35.2 billion and RMB38.1 billion, with strong revenue growth expected to be mainly due to BRUKINSA's ® leading position in the United States and continued expansion in Europe and other important markets around the world. At the same time, based on the improvement of the company's product portfolio and production efficiency, it is expected that the gross profit margin will be in the median range of 80% to 90% in 2025. It is expected that the total R&D expenses, selling and administrative expenses will be between RMB29.5 billion and RMB31.9 billion in 2025.

[7 days 4 board Chengbang shares: the holding subsidiary Xincun Electronics is mainly engaged in the research and development and design of semiconductor memory, and the current business scale is small].

Chengbang shares (603316.SH) issued a stock trading risk warning announcement, saying that the company's shares will be limited for three consecutive trading days from February 24 to 26, 2025, with a cumulative deviation of 20%, which is an abnormal fluctuation in stock trading. The company expects to achieve operating income of about 360 million yuan in 2024, net profit of about -86 million yuan, and non-net profit of about -89 million yuan, which is still a loss. The company's holding subsidiary, Dongguan Xincun Chengbang Technology Co., Ltd. (hereinafter referred to as Xincun Electronics), is mainly engaged in the research and development, design, production and sales of semiconductor memory. In 2024, the operating income and net profit of Xincun Electronics are expected to contribute about 122 million yuan and 1.02 million yuan respectively, which is in a state of meager profit.

[2 Lianban Longxi shares: the company's fundamentals have not changed, and the main business is spherical bearings, tapered roller bearings, etc.].

Longxi Co., Ltd. issued an announcement on abnormal fluctuations in stock trading, saying that the company's main business is the research and development, production and sales of spherical bearings, tapered roller bearings, gears/gearboxes. The company's fundamentals have not changed, but since the beginning of this year, in the face of many difficulties and challenges such as increasingly fierce market competition, rising labor costs and tariffs on product exports, the company will take the initiative to take measures to maintain stable main business and operating performance.

[China Micro Corporation: Net profit in 2024 will be 1.626 billion yuan, down 8.93% year-on-year].

AMEC released a performance report, with an operating income of about 9.065 billion yuan in 2024, a year-on-year increase of 44.73%; net profit was 1.626 billion yuan, down 8.93% year-on-year. Among them, the revenue of etching equipment was about 7.277 billion yuan, a year-on-year increase of 54.73%; The sales revenue of LPCVD equipment in 2024 will be about 156 million yuan. In 2024, the company's R&D investment will be about 2.452 billion yuan, a year-on-year increase of 94.31%, accounting for about 27.05% of operating income.

[Shengyi Technology: net profit in 2024 will be 1.744 billion yuan, a year-on-year increase of 49.81%].

Shengyi Technology released its 2024 annual performance report, with a total operating income of 20.388 billion yuan, a year-on-year increase of 22.92%; net profit attributable to shareholders of listed companies was 1.744 billion yuan, a year-on-year increase of 49.81%. During the reporting period, the company's production and sales of copper clad laminates increased year-on-year, and the sales structure was optimized, which made the revenue and gross profit margin of copper clad laminate products increase year-on-year, and promoted the increase in profitability. Shengyi Electronics Co., Ltd., a subsidiary of its subsidiary, has achieved a turnaround in net profit with the growth of market demand for multilayer printed circuit boards with high layers, high precision, high density and high reliability.

[Jinshan Office: net profit of 1.645 billion yuan in 2024, a year-on-year increase of 24.84%].

Kingsoft Office announced that in 2024, it will achieve operating income of 5.121 billion yuan, a year-on-year increase of 12.40%; net profit attributable to owners of the parent company was 1.645 billion yuan, a year-on-year increase of 24.84%. Focusing on the core strategic direction of "multi-screen, cloud, content, collaboration, and AI", the company continues to increase R&D investment in the field of collaboration and AI, promote product iteration and upgrading, and enhance market competitiveness and industry influence.

[Yuncong Technology: net loss of 637 million yuan in 2024].

Cloudwalk Technology released a performance report, and the company will achieve a total operating income of 398 million yuan in 2024, a year-on-year decrease of 36.60%; Net loss attributable to owners of the parent company was 637 million yuan, compared with a net loss of 643 million yuan in the same period last year. Mainly due to the company's initiative to promote the strategic adjustment of product portfolio and customer structure, the scale of new orders signed has shrunk in stages. At the same time, in order to strengthen the demonstration effect of some projects, the company took the initiative to transfer the gross profit margin of some projects, dragging down the overall gross profit margin year-on-year. In addition, the depreciation expense incurred by the company's purchase of a large number of computing power servers increased year-on-year, increasing the financial burden. Although the expenses during the period decreased year-on-year, the company's loss scale was basically the same as that in the previous period.

[Yuntian Lifei: net loss of 573 million yuan in 2024].

Yuntian Lifei released a performance report, with a total operating income of 918 million yuan in 2024, an increase of 81.42% over the same period of the previous year; The net loss was 573 million yuan. During the reporting period, the company's main business operation remained stable, and the company's investment in technology research and development and market expansion increased. At the same time, in order to grasp the development opportunities of the industry and consolidate the competitive advantage of the company's core technology, the company continued to increase investment in high-end talents and underlying technologies. In addition, the company said that the increase in total operating income in 2024 is mainly due to the increase in sales revenue of intelligent computing operation business and intelligent hardware products, and the revenue of intelligent hardware products mainly comes from the newly added holding company Shenzhen Weicheng Technology Co., Ltd. in the current period.

Business & Performance

[Zhongwei Semiconductor: net profit of 135 million yuan in 2024 to turn losses into profits].

AMEC released a performance report, achieving a total operating income of 911 million yuan in 2024, a year-on-year increase of 27.72%; The net profit attributable to the owners of the parent company was 135 million yuan, turning losses into profits. The company said that the company has effectively strengthened the program development and service capabilities of brushless motor control and drive chips, improved customer satisfaction, continued to increase new customers and new projects, achieved breakthroughs in the application of artificial intelligence servers and robots, and nearly doubled the revenue of brushless motor control and drive chips year-on-year.

[Wealth trend: net profit in 2024 will be 305 million yuan, a year-on-year decrease of 1.83%].

According to the Fortune Trend announcement, the total operating income in 2024 will be 388 million yuan, a year-on-year decrease of 10.71%; net profit attributable to owners of the parent company was 305 million yuan, a year-on-year decrease of 1.83%. Mainly affected by the changes in the macroeconomic environment and the decrease in customer demand from institutional customers in the securities market, the sales revenue and contract amount of software and hardware this year were adjusted compared with the previous period, which had a certain impact on the company's revenue and net profit. The increase of 40% in share capital compared with the beginning of the period was due to the conversion of capital reserve into share capital during the reporting period.

[United Imaging Medical: net profit in 2024 will be 1.262 billion yuan, down 36.08% year-on-year].

United Imaging Medical announced that it will achieve a total operating income of 10.3 billion yuan in 2024, a year-on-year decrease of 9.73%; net profit attributable to owners of the parent company was 1.262 billion yuan, down 36.08% year-on-year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 1.010 billion yuan, down 39.32% year-on-year. Mainly affected by the pace of domestic equipment renewal policy, the overall scale of the industry has shrunk significantly compared with the same period last year, although the company's domestic market share remains at the leading level, domestic revenue is still lower than the same period last year. At the same time, the company continued to strengthen overseas market development and the introduction of innovative products to achieve sustained and rapid growth in overseas revenue.

[Obi Zhongguang: net loss of 59.9877 million yuan in 2024].

Obi Zhongguang released a performance report, with a total operating income of 562 million yuan in 2024, an increase of 56.16% over the same period of the previous year; The net profit attributable to the owners of the parent company was -59.9877 million yuan, compared with -276 million yuan in the same period last year. During the reporting period, the company accelerated the promotion of emerging scenarios and continued to enrich and optimize its product structure, achieving rapid growth in AIOT and other fields. With the continuous expansion of the downstream market and the smooth commissioning of the company's 3D visual perception industry intelligent manufacturing base, the company's production capacity scale level and mass production planning rhythm will continue to improve and optimize.

[JinkoSolar: net profit in 2024 will be 90.5409 million yuan, a year-on-year decrease of 98.78%].

JinkoSolar announced that in 2024, the company will achieve a total operating income of 92.621 billion yuan, a year-on-year decrease of 21.96%; The net profit attributable to the owners of the parent company was 90.5409 million yuan, a year-on-year decrease of 98.78%. The main reason is the decline in the profit of the main business due to the decline in the price of photovoltaic products.

[Junshi Biosciences: net loss of 1.282 billion yuan in 2024].

Junshi Biosciences released a performance report, and in 2024, the company achieved a total operating income of 1.948 billion yuan, a year-on-year increase of 29.67%; The net loss attributable to owners of the parent company was 1.282 billion yuan, compared with a net loss of 2.283 billion yuan in the same period last year. During the reporting period, the operating profit, total profit, net profit attributable to owners of the parent company, net profit attributable to owners of the parent company after deducting non-recurring gains and losses, basic earnings per share, and weighted average return on equity decreased compared with the same period last year, mainly due to the company's active implementation of the action plan of "improving quality and efficiency and emphasizing returns", continuously strengthening various expense control, reducing unit production costs, improving sales efficiency, and focusing resources on more potential R&D projects.

[China Resources Micro: Net profit in 2024 will be 776 million yuan, down 47.55% year-on-year].

China Resources Micro released a performance report, achieving a total operating income of 10.119 billion yuan in 2024, a year-on-year increase of 2.2%; net profit was 776 million yuan, down 47.55% year-on-year; Basic earnings per share was 0.59 yuan. During the reporting period, due to the superposition effect of capacity release and industry destocking, product price competition was fierce, and at the same time, major company-level projects, such as packaging base projects, 12-inch production line projects in Chongqing and Shenzhen, were in the stage of ramp-up and construction, and the depreciation impact brought by heavy asset investment in the early stage caused certain pressure on the company's profit indicators.

[BeiGene: net loss of 4.978 billion yuan in 2024].

BeiGene (688235.SH) released a performance report, achieving a total operating income of 27.214 billion yuan in 2024, a year-on-year increase of 56.2%; The net profit loss was 4.978 billion yuan, compared with a loss of 6.716 billion yuan in the same period last year. During the reporting period, the company's operating profit, total profit and net profit attributable to owners of the parent company after deducting non-recurring gains and losses decreased compared with the same period last year, mainly due to the substantial increase in product revenue and the improvement of operating efficiency driven by expense management.

[Trina Solar: net loss of 3.455 billion yuan in 2024].

Trina Solar (688599.SH) released a performance report, achieving a total operating income of 80.334 billion yuan in 2024, a year-on-year decrease of 29.15%; The net profit loss attributable to the owners of the parent company was 3.455 billion yuan, compared with a net profit of 5.531 billion yuan in the same period last year, a year-on-year loss. During the reporting period, the company's operating profit, total profit, net profit attributable to owners of the parent company and net profit attributable to owners of the parent company after deducting non-recurring gains and losses decreased by 154.15%, 156.43%, 162.46% and 190.35% respectively, mainly due to the year-on-year decline in the selling price of photovoltaic module related products and the decline in profitability of photovoltaic products due to the supply and demand of the photovoltaic industry chain during the reporting period.

[Daqo Energy: net profit loss of 2.718 billion yuan in 2024].

Daqo Energy (688303.SH) announced that it will achieve operating income of 7.411 billion yuan in 2024, a year-on-year decrease of 54.62%; Net profit attributable to shareholders of listed companies was -2.718 billion yuan. Mainly due to the decline in polysilicon prices, the company's performance decreased compared with the same period last year.

[Baili Tianheng: net profit of 3.658 billion yuan in 2024, turning losses into profits year-on-year].

Baili Tianheng announced that the total operating income in 2024 will be 5.823 billion yuan, a year-on-year increase of 936.31%; The net profit attributable to the owners of the parent company was 3.658 billion yuan, a year-on-year turnaround. This was mainly due to the Company's receipt of an irrevocable, non-deductible down payment of US$800 million from Bristol-Myers Squibb, an overseas partner of its core product BL-B01D1, based on the cooperation agreement.

[BIWIN Storage: Net profit of 176 million yuan in 2024 will turn losses into profits year-on-year].

BIWIN Storage (688525.SH) announced that in 2024, it will achieve operating income of 6.704 billion yuan, a year-on-year increase of 86.71%; The net profit attributable to the owners of the parent company was 176 million yuan, a year-on-year turnaround. The storage industry has recovered, and the company's business has grown significantly. The company's representative storage products such as ePOP have performed well, and have entered the supply chain system of well-known AI/AR glasses manufacturers at home and abroad such as Meta, Rokid, Thunderbird Innovation, and Shanji, as well as well-known smart wearable manufacturers at home and abroad, such as Google, Xiaotiancai, and Xiaomi. In 2025, with the increase in the volume of AI glasses, the company's cooperation with key customers such as Meta will continue to deepen, which will promote the continuous growth of the company's smart wearable storage business.

[Espressif Technology: Net profit increased by 150% year-on-year in 2024].

Espressif Systems (688018.SH) released a performance report, with a total operating income of 2.007 billion yuan in 2024, an increase of 40.04% year-on-year. net profit attributable to owners of the parent company was 340 million yuan, an increase of 149.54% year-on-year. From the application side, the core application markets such as smart home, smart lighting and consumer electronics have reached a total growth of more than 30%, while emerging application markets such as energy management, tools and equipment, and big health are more prominent, all showing rapid growth.

Stock price movements

[Yokogawa Precision: The company is not involved in the humanoid robot business].

Yokogawa Precision (300539.SZ) announced that it is concerned about the recent market interest in the concept of humanoid robots, and that the reducer/actuator products produced by the company are mainly used in home appliances and automobiles, and are not involved in the humanoid robot business.

[Huapei Power: The wholly-owned robot subsidiary has not yet been established, and the related business is still in the research and development stage].

Huapei Power (603121.SH) issued an announcement on abnormal fluctuations in stock trading, saying that the company's shares will deviate from the daily closing price increase by more than 20% in three consecutive trading days on February 25, February 26 and February 27, 2025, which is an abnormal fluctuation in stock trading. According to the company's self-inspection, the company's overall production and operation situation is normal, the internal and external business environment has not undergone major adjustments, and the main business has not undergone major changes. In addition, the company's wholly-owned robot subsidiary has not yet been established, and the related business is still in the research and development stage, and has not formed sales revenue, which will not have a significant impact on the company's performance.

[17 days and 13 boards Hangzhou Iron and Steel Co., Ltd.: The stock price is seriously detached from the fundamentals and there is a high risk of speculation].

Hangzhou Iron and Steel Co., Ltd. (600126.SH) issued a serious abnormal fluctuation in stock trading and risk warning announcement, saying that the stock has risen by 217.24% since January 22, 2025, and as of the close of trading on February 27, 2025, the company's share price is 14.72 yuan, and the stock price has been seriously detached from the company's fundamentals, with an average turnover rate of 17.48% in the last three trading days, a high turnover rate, overheated market sentiment, and a high risk of speculation and short-term decline in stock prices. The company's main business is the production and sales of steel and its rolled products, and the computing power business accounts for a very small proportion. The company expects that the net profit attributable to the owners of the parent company in 2024 will be about -630 million yuan, and there will be a loss. The company does not have material information that should be disclosed but has not been disclosed.

[Dimensity Technology: The company has no business cooperation with DeepSeek for the time being].

Dimensity Technology (300245.SZ) announced that the company focuses on information technology services, mainly including IT support and maintenance services, IT outsourcing services, IT professional services and other IT solutions and services. At present, the company's business activities are normal, the company's business and internal and external business environment have not undergone major changes, and the company has no business cooperation with DeepSeek for the time being.

[5 Lianban Dawei Technology: The company's business has not undergone major changes and is mainly engaged in IDC business].

Dawei Technology (600589.SH) issued a risk warning announcement, saying that the company is an Internet integrated service provider mainly engaged in IDC business, providing customers with cabinet leasing services, network transmission and value-added services, and related operation and maintenance services. After self-inspection, the company's current business situation is normal, there has been no major change in the main business, and there has been no major change in the external market environment and industry policies. Please pay attention to investment risks, make rational decisions and invest prudently.

Private placement & financing & repurchase

[Haisco: It is planned to raise no more than 1.365 billion yuan to invest in new drug research and development projects].

Haisco announced the 2025 annual plan to issue A shares to specific targets, and the number of shares to be issued to specific targets this time does not exceed 70,000,000 shares (including the number of shares), which is not more than 30% of the total share capital before the issuance according to the current company's total share capital. The total amount of funds raised by the issuance of shares to specific targets does not exceed 1.365 billion yuan (including this number), and the net amount after deducting the issuance expenses is intended to be 965 million yuan for investment in new drug research and development projects, and 400 million yuan for supplementing working capital.

[Li Yuanheng: It is planned to repurchase the company's shares for employee stock ownership plans or equity incentives with 30 million yuan to 40 million yuan].

Li Yuanheng (688499.SH) announced that Zhou Junxiong, the actual controller, chairman and president of the company, proposed to repurchase part of the company's issued RMB ordinary shares (A shares) with its own funds and/or self-raised funds through the Shanghai Stock Exchange trading system in a centralized bidding transaction, and the repurchased company's shares are intended to be used for employee stock ownership plans or equity incentives. The total amount of repurchase funds shall not be less than RMB30 million (inclusive) and not more than RMB40 million (inclusive), and the upper limit of the repurchase price shall not exceed RMB36.60 per share. The repurchase period shall be within 12 months from the date of the board of directors' deliberation and approval of the share repurchase plan.

Winning & Approved

[Fosun Pharma: Holding subsidiary obtained approval for drug clinical trial].

Fosun Pharma announced that its holding subsidiary, Jiangsu Xingsheng Xinhui Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for the clinical trial of XS-03 tablets in combination with FOLFOX or FOLFIRI and bevacizumab for the treatment of RAS mutant metastatic colorectal cancer. Xinhui intends to commence a Phase Ib/II clinical trial of this treatment regimen in China when conditions are met. XS-03 is a small molecule oral PLK1 inhibitor independently developed by Fosun Pharma, which mainly inhibits cell cycle regulators and induces mitotic arrest, so as to achieve anti-tumor effects such as inhibiting tumor cell proliferation and promoting tumor cell apoptosis. As of the date of this announcement, XS-03 is in Phase I clinical trials in China for the treatment of RAS mutant advanced solid tumors.

[General Design Institute: The company and its subsidiaries recently won a total of 656 million yuan for the project].

The General Design Institute (603357.SH) announced that recently, the company and its subsidiaries received a number of project winning notices, with a total bid amount of 656 million yuan.

[Huakang Medical: Won the bid for the construction project of animal biosafety level 3 laboratory of Shanghai Jiao Tong University].

Huakang Medical (301235.SZ) announced that the consortium formed by the company and Bofit Environmental Technology Co., Ltd. received the "Notice of Winning the Bid" issued by the bidding agency Shanghai Shenkang Health Infrastructure Management Co., Ltd., confirming that the consortium was the winning supplier of the "Shanghai Jiao Tong University Animal Biosafety Level 3 Laboratory Construction Project". The winning bid price is 107,505,452 yuan, and the company, as the leader of the consortium, is expected to share no less than 100 million yuan. The execution of the project is expected to have a positive impact on the company's net profit for future years.

[Jianyou Co., Ltd.: The subsidiary obtained the approval of the US FDA for the transfer of the production site of norepinephrine tartrate injection].

Jianyou Co., Ltd. (603707.SH) announced that Meitheal Pharmaceuticals, Inc., a subsidiary of the company, received an approval letter from the US FDA for the transfer of the production site of norepinephrine tartrate injection, approving the production at the site of the company's subsidiary, Jianjin Pharmaceutical Co., Ltd. The drug is used for the treatment of severe acute hypotension in adults, and there are currently 12 other generic drugs on sale in the United States. The company has invested about RMB 586,300 in research and development on the project. The newly approved products will be scheduled for marketing in the United States in the near future, which is expected to have a positive impact on the company's operating results.

Underweight & Overweight

[Huashu Hi-Tech: Xingwang Construction plans to reduce its holdings of no more than 2% of the company's shares].

Huashu Hi-Tech (688433.SH) announced that Hunan Xingwang Construction Co., Ltd. (hereinafter referred to as "Xingwang Construction"), a 21.94% shareholder, plans to reduce its holdings of the company's shares by no more than 8,283,400 shares (accounting for 2% of the company's total share capital) through block trading within 3 months after 15 trading days.

[Tanaka Seiki: Rose Capital plans to reduce its holdings of no more than 1.34% of the company's shares].

Tanaka Seiki (300461.SZ) announced that the shareholder Rose Capital Co., Ltd. holds 6.34% of the company's shares, and plans to reduce its holdings of the company's shares obtained through agreement transfer through block trading and centralized bidding, and it is expected that the reduction of shares will not exceed 2.0805 million shares (accounting for 1.34% of the company's total share capital).

Transfers & Acquisitions & Investments

[Yapp shares: a wholly-owned subsidiary has obtained the designated product sales of the North American automobile main engine factory project in the life cycle is expected to be about 3.1 billion yuan].

Yapp announced that its wholly-owned subsidiary, Yapp American Automotive Systems Co., Ltd., received a project designation notice from a North American automotive main engine factory that it will provide customers with more than 2 million sets of high-pressure fuel tank systems, and the product sales of the project models are expected to be about 3.1 billion yuan in the life cycle. This designation demonstrates the customer's full recognition of the company's technical capabilities, cost and quality control, and will have a positive impact on the company's future development in North America. However, the fixed-point notice does not reflect the customer's final actual purchase quantity, which is subject to the order settlement amount.

[Beijing Human Resources: It is planned to transfer 100% of the equity of the subsidiary Huangsi Company at a transaction price of not less than 441 million yuan].

Beijing Human Resources (600861.SH) announced that the company intends to transfer 100% of the equity of its wholly-owned subsidiary, Beijing Chengxiang Huangsi Commercial Building Co., Ltd., to Beijing Jingguoguan Real Estate Investment Co., Ltd., a related party, by way of agreement transfer, with a transfer price of not less than 440.7115 million yuan. Real Estate Investment is a wholly-owned subsidiary of Beijing State-owned Capital Operation and Management Co., Ltd., the controlling shareholder of the Company, and this transaction constitutes a connected transaction.

[Evergreen Group: Signed a strategic cooperation framework agreement with Zhongke Information Control (Beijing) Technology Co., Ltd.].

Evergreen Group (002616.SZ) announced that the company signed a "strategic cooperation framework agreement" with Zhongke Information Control (Beijing) Technology Co., Ltd. on February 26. The two parties hope to jointly promote the digital transformation and intelligent upgrading of the industry in which they are located, empower the sustainable development of the industry, and extend to areas in need. The two parties to the transaction also made it clear in the framework agreement that the two parties agreed that the company would acquire 49% of the equity of Beijing Zhongke Information Control Big Data Co., Ltd.

[Huaxin New Materials: The subsidiary plans to invest 80 million yuan to build a functional membrane material project with an annual output of 5,000 tons].

Huaxin New Materials announced that the company's wholly-owned subsidiary, Huaxin High-tech, plans to invest 80 million yuan to build an "annual output of 5,000 tons of functional membrane materials project", and the project construction period is expected to be 18 months. The main body of the project is Huaxin High-tech, and the construction site is located in the east factory area of Zhujiang Road Company, Xiyi High-tech Zone, Xinyi City, Jiangsu Province. The source of funding for the project is CEFC High-tech's own funds or self-raised funds. The project aims to optimize and adjust the product structure, expand the business scale, and enhance the company's core competitiveness and sustainable development ability.

Miscellaneous

[Delisting Zhuo Lang: the company's shares are terminated from listing].

Delisting Zhuo Lang (600225.SH) announced that the company's shares will enter the delisting period on February 7, 2025, and as of February 27, 2025, it has been traded for 15 trading days, and the delisting period has ended. The Shanghai Stock Exchange will delist the company's shares on March 6, 2025, and the company's shares will be terminated from listing. The company will be transferred to the national small and medium-sized enterprise share transfer system, relying on the original securities company agency share transfer system to establish and manage the two network companies and delisted companies for listing and transfer. The sponsoring securities firm is Tianfeng Securities Co., Ltd.

[BOE A: BOE Energy, a holding subsidiary, was approved to be listed on the New Third Board].

BOE A (000725.SZ) announced that the company's holding subsidiary, BOE Energy Technology Co., Ltd. (hereinafter referred to as "BOE Energy"), recently received the "Letter on Agreeing to the Public Transfer of BOE Energy Technology Co., Ltd. Shares and Listing on the National Equities Exchange and Quotations System" issued by the National Equities Exchange and Quotations Company. After BOE Energy is listed on the New Third Board, it is still a holding subsidiary within the scope of the company's consolidated statements. Collection

Read 1360

I want to comment

You are welcome to post valuable comments, advertisements and discord comments will be deleted, and comments will be banned from your account.